Search

everythinglearnresearchcommunity

for

Search:↓

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Morroniside may help hair grow and stay in its growth phase by affecting certain cell signals.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Lrig1 could be a marker for advanced sebaceous carcinoma.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Finasteride may affect male fertility by interfering with specific sperm signaling.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Finasteride may improve prostate cancer treatment outcomes.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Different amounts of daylight affect cashmere growth in goats by changing the activity of certain genes and molecules.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.